Muscular Dystrophy Mystery Solved?
An international team of researchers headed by an investigator from Fred Hutchinson Cancer Research Center have made a critical advance in determining the cause of a common form of muscular dystrophy.
Food for Thought
A new study suggests efforts to determine the nutritional effect on Alzheimer's disease could be improved by using nutrient “biomarkers” in elderly people at risk for dementia.
New Treatment for MS Approved in U.S., Europe
Pharmaceutical company Novartis AG's multiple sclerosis (MS) drug, Gilenya, has been approved for use in the United States and now Europe to treat relapsing-remitting forms of the disease.
Unpacking Parkinson's Mysteries
Swedish researchers have found that damaged alpha-synuclein proteins can spread in Parkinson's disease similar to an infection model found in conditions like mad cow disease.
Deep brain stimulation has proven beneficial for some treatment-resistant cases of obsessive-compulsive disorder (OCD), depressive disorders and Tourette syndrome.
Name that Emotion
Patients with Parkinson's disease find it more difficult to gauge and recognize expressions of emotion in other people's faces and voices, according to new research.
Nutty but True
Eating a handful of pecans every day may provide protection against the progression of motor neuron degeneration due to age or possibly even diseases like amyotrophic lateral sclerosis (ALS).
Legs That Won't Quit
Adults with fibromyalgia are more likely to experience restless legs syndrome (RLS), according to a new study, which suggests treatment for RLS may improve sleep and quality of life for these patients.
The Blood Trade
New guidelines recommend plasma exchange for patients with severe relapses of multiple sclerosis (MS) and for those with nerve disorders such as neuropathy.
Flipping Off Inflammation
A "master switch" protein in white blood cells has been found to influence whether the cells promote or hinder inflammation, according to a new study.